Drug Profile
AVR 560
Alternative Names: AVR-560; STS-560Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator AllaChem
- Class Antivirals; Indoles; Small molecules
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Hepatitis-C(Treatment-naive) in USA (PO)
- 30 Sep 2013 Phase-I clinical trials in Hepatitis C (in volunteers) in USA (PO)